Pharmascience's generic Paliperidone Palmitate Prolonged-Release Injectable Suspension received for

MONTREAL, Nov. 12, 2019 /CNW Telbec/ - Pharmascience Inc. is proud to announce that the US Food and Drug Administration (FDA) communicated on October 31, 2019, ... Lees verder

Bron:

ANP Pers support